BOCA RATON, Fla. and FARGO, N.D., Dec. 16, 2011 /PRNewswire/ -- Crystal3 Labs, Inc., a cGMP contract research organization (CRO) based in Boca Raton, FL, announced today that it has been acquired by an individual investor, Vithalbhai Dhaduk, M.D., of Fargo, ND. Financial terms of the transaction were not disclosed. The company also announced an immediate name change to Global Pharma Analytics.
Founded in 2007, Global Pharma Analytics provides pharmaceutical research services and analytical testing of drugs and medical devices for the pharmaceutical and biotechnology industries. The company employs 6 people in Florida.
"We are very excited about this development as it allows us to dramatically expand our business and our growth," said Satish Chandran, Ph.D., Chief Executive Officer at Global Pharma. "Our name change reflects our increased investment in developing CRO services to meet the needs of pharmaceutical and biotechnology companies conducting research around the world. We look forward to working closely with Dr. Dhaduk, as his wisdom and extensive industry experience will be very valuable to us and to our clients."
ABOUT GLOBAL PHARMA ANALYTICS
Global Pharma Analytics provides a wide range of professional services to support pharmaceutical, nutritional and specialty chemical companies, including analytical testing, stability programs, laboratory maintenance and support, and consulting services. In addition to pharmaceutical businesses, other industries served, include nutraceuticals, medical devices, packaging, specialty chemicals, food products, cosmetics and veterinary science.
VITHALBHAI DHADUK, M.D.
Dr. Dhaduk serves as Chairman of several biotech companies he cofounded, among them, Somahlution, Apicore, Synerex Pharmaceuticals, Nuron-Biotech and Core-Pharma. Dr. Dhaduk provides leadership and guidance in product development, marketing, partner relationships, finance and corporate govern
|SOURCE Crystal3 Labs, Inc.|
Copyright©2010 PR Newswire.
All rights reserved